Log in
(Ad)
Roger's "Overnight Fortune" stock picks have been 8X more profitable than buy Amazon in 1997, turning a tiny $3k model portfolio into over $17M.

And he's about to give you the ticker symbol of its next pick...

NASDAQ:PETS - Petmed Express Stock Price, Forecast & News

$27.26
+0.75 (+2.83 %)
(As of 01/20/2020 06:31 AM ET)
Today's Range
$26.40
Now: $27.26
$27.35
50-Day Range
$21.72
MA: $23.45
$27.26
52-Week Range
$15.00
Now: $27.26
$27.80
Volume905,798 shs
Average Volume429,479 shs
Market Capitalization$549.83 million
P/E Ratio21.13
Dividend Yield3.96%
Beta0.62
PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes. Read More…

Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryInternet Retail
SectorRetail/Wholesale
Current SymbolNASDAQ:PETS
CUSIP71638210
Phone561-526-4444

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$283.42 million
Cash Flow$1.93 per share
Book Value$6.51 per share

Profitability

Net Income$37.74 million

Miscellaneous

Employees187
Market Cap$549.83 million
Next Earnings Date1/21/2020 (Confirmed)
OptionableOptionable

Receive PETS News and Ratings via Email

Sign-up to receive the latest news and ratings for PETS and its competitors with MarketBeat's FREE daily newsletter.


(Ad)


A devastating technical glitch could crush the next generation of wireless technology before it even launches. With trillions of dollars and millions of jobs at stake, one company with the "5G fix" could put as much as $234,770 in your pocket this year. But Wall Street vultures are circling... you'll need to move quickly or risk missing this $5 bargain.

Petmed Express (NASDAQ:PETS) Frequently Asked Questions

What is Petmed Express' stock symbol?

Petmed Express trades on the NASDAQ under the ticker symbol "PETS."

How often does Petmed Express pay dividends? What is the dividend yield for Petmed Express?

Petmed Express announced a quarterly dividend on Monday, October 21st. Investors of record on Monday, November 4th will be paid a dividend of $0.27 per share on Friday, November 15th. This represents a $1.08 dividend on an annualized basis and a yield of 3.96%. The ex-dividend date of this dividend is Friday, November 1st. View Petmed Express' Dividend History.

How were Petmed Express' earnings last quarter?

Petmed Express Inc (NASDAQ:PETS) issued its quarterly earnings data on Monday, October, 21st. The company reported $0.33 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.26 by $0.07. The firm had revenue of $69.94 million for the quarter, compared to analyst estimates of $69.65 million. Petmed Express had a return on equity of 20.45% and a net margin of 9.62%. The business's revenue was down 2.0% on a year-over-year basis. During the same quarter last year, the business earned $0.52 EPS. View Petmed Express' Earnings History.

When is Petmed Express' next earnings date?

Petmed Express is scheduled to release their next quarterly earnings announcement on Tuesday, January 21st 2020. View Earnings Estimates for Petmed Express.

What price target have analysts set for PETS?

2 equities research analysts have issued 1-year price objectives for Petmed Express' shares. Their forecasts range from $20.00 to $29.00. On average, they anticipate Petmed Express' stock price to reach $24.50 in the next year. This suggests that the stock has a possible downside of 10.1%. View Analyst Price Targets for Petmed Express.

What is the consensus analysts' recommendation for Petmed Express?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Petmed Express in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Petmed Express.

Has Petmed Express been receiving favorable news coverage?

Headlines about PETS stock have trended positive on Monday, according to InfoTrie. InfoTrie rates the sentiment of media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Petmed Express earned a coverage optimism score of 3.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Petmed Express.

Are investors shorting Petmed Express?

Petmed Express saw a drop in short interest in December. As of December 31st, there was short interest totalling 6,890,000 shares, a drop of 6.1% from the December 15th total of 7,340,000 shares. Based on an average daily trading volume, of 706,600 shares, the short-interest ratio is presently 9.8 days. Currently, 35.7% of the shares of the company are short sold. View Petmed Express' Current Options Chain.

Who are some of Petmed Express' key competitors?

What other stocks do shareholders of Petmed Express own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Petmed Express investors own include Intel (INTC), AT&T (T), Alibaba Group (BABA), NVIDIA (NVDA), Micron Technology (MU), Netflix (NFLX), Ford Motor (F), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and Gilead Sciences (GILD).

Who are Petmed Express' key executives?

Petmed Express' management team includes the folowing people:
  • Mr. Menderes Akdag, CEO, Pres & Director (Age 58)
  • Mr. Bruce S. Rosenbloom, CFO & Treasurer (Age 50)
  • Ms. Alison Berges, Corp. Sec. & Gen. Counsel

Who are Petmed Express' major shareholders?

Petmed Express' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Scout Investments Inc. (0.60%), Inlet Private Wealth LLC (0.35%), 6 Meridian (0.16%) and Nisa Investment Advisors LLC (0.02%). Company insiders that own Petmed Express stock include Frank J Formica, Gian Fulgoni, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Institutional Ownership Trends for Petmed Express.

Which major investors are selling Petmed Express stock?

PETS stock was sold by a variety of institutional investors in the last quarter, including Inlet Private Wealth LLC and Scout Investments Inc.. View Insider Buying and Selling for Petmed Express.

Which major investors are buying Petmed Express stock?

PETS stock was bought by a variety of institutional investors in the last quarter, including 6 Meridian and Nisa Investment Advisors LLC. View Insider Buying and Selling for Petmed Express.

How do I buy shares of Petmed Express?

Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Petmed Express' stock price today?

One share of PETS stock can currently be purchased for approximately $27.26.

How big of a company is Petmed Express?

Petmed Express has a market capitalization of $549.83 million and generates $283.42 million in revenue each year. Petmed Express employs 187 workers across the globe.View Additional Information About Petmed Express.

What is Petmed Express' official website?

The official website for Petmed Express is http://www.1800petmeds.com/.

How can I contact Petmed Express?

Petmed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.


MarketBeat Community Rating for Petmed Express (NASDAQ PETS)

Community Ranking:  1.5 out of 5 (star half star)
Outperform Votes:  180 (Vote Outperform)
Underperform Votes:  431 (Vote Underperform)
Total Votes:  611
MarketBeat's community ratings are surveys of what our community members think about Petmed Express and other stocks. Vote "Outperform" if you believe PETS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PETS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/20/2020 by MarketBeat.com Staff

Featured Article: Golden Cross

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel